reports
Fairfax Announces the Passing of Eric Salsberg
Fairfax Announces the Passing of Eric Salsberg TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announces with great sadness the passing of Eric P. Salsberg, who joined Fairfax in 1988 after acting as counsel to Fairfax on every major transaction it undertook since its founding in 1985. Rick served as Vice President – Corporate Affairs and Corporate Secretary for Fairfax, and provided strategic advice and guidance on countless transactions undertaken by the company over the years. “For all of Fairfax’s history, Ricky has acte...
NKT Photonics frasalg godkendt af Erhvervsstyrelsen
NKT Photonics frasalg godkendt af Erhvervsstyrelsen Selskabsmeddelelse 6. maj 2024 Meddelelse nr. 12 NKT Photonics frasalg godkendt af Erhvervsstyrelsen I selskabsmeddelelse nr. 11 af 24. juni 2022 offentliggjorde NKT A/S (NKT) indgåelse af en aftale med Photonics Management Europe S.R.L, et 100% ejet datterselskab af Hamamatsu Photonics K.K, Japan (Køber) om frasalg af NKT Photonics. Gennemførelsen af transaktionen var betinget af påkrævede myndighedsgodkendelser, hvilket blev modtaget fra Tyskland, Storbritannien og USA. Godkendelse blev ikke opnået i Danmark i maj 2023. I ju...
Divestment of NKT Photonics approved by the Danish Business Authority
Divestment of NKT Photonics approved by the Danish Business Authority Company Announcement 6 May 2024 Announcement No. 12 Divestment of NKT Photonics approved by the Danish Business Authority In company announcement no. 11 of 24 June 2022, NKT A/S (NKT) announced to have entered into an agreement to divest NKT Photonics to Photonics Management Europe S.R.L, a 100% owned subsidiary of Hamamatsu Photonics K.K, Japan (the Purchaser). Closing of the transaction was subject to regulatory approvals which were obtained from Germany, United Kingdom, and the United States, however, not app...
ZJLD Group Inc: 1 director
A director at ZJLD Group Inc sold 9,000,000 shares at 10.580HKD and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
EYG Gayrimenkul Yatirim Ortakligi: 1 director
A director at EYG Gayrimenkul Yatirim Ortakligi sold 2,800,000 shares at 10.420TRY and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the l...
Vow ASA: Invitation to Vow ASA first quarter 2024 presentation and Q&A
Vow ASA: Invitation to Vow ASA first quarter 2024 presentation and Q&A Vow ASA (OSE: VOW) is pleased to invite shareholders, investors, analysts, and other interested parties to a presentation of the results for the first quarter of 2024 at 09:00 CET on Tuesday May 14, 2024. Personal attendance is welcomed at Haakon VII's gate 2, 0161 Oslo. The session will also be streamed via webcast. To register and follow the presentation online, please copy and paste the following link into your browser, click Attend and register your e-mail: /landingpage/vowasa/20240514_1/ For further informatio...
- ABGSC Capital Goods Research
- Adrian Gilani
- ABGSC Construct. & Real Estate Research
- Fredrik Stensved
- Markus Henriksson
- Viktor Stenlöf
Tailam Tech Construction Holdings Limited: 1 director
A director at Tailam Tech Construction Holdings Limited bought 26,870,000 shares at 0.000HKD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors...
Moody's Ratings affirms Bank First's Baa1 rating; outlook remains stab...
Moody's Ratings (Moody's) has affirmed the long-term issuer rating of Baa1 for Bank First, the trading name of Victoria Teachers Limited, based on the bank's strong asset quality and capitalization. At the same time, Moody's has maintained the stable rating outlook. IMPORTANT NOTICE: MOODY'S RATIN...
Kforce Inc. Announces Transfer of Listing of Common Stock to the New Y...
Kforce Inc. Announces Transfer of Listing of Common Stock to the New York Stock Exchange TAMPA, Fla., May 06, 2024 (GLOBE NEWSWIRE) -- Kforce Inc. (Nasdaq: KFRC) (“Kforce”), a solutions firm that specializes in technology and professional staffing services, announced today that it will transfer the listing and trading of its common stock to the New York Stock Exchange (“NYSE”) from the Nasdaq Stock Market LLC (“Nasdaq”). Kforce’s common stock is expected to begin trading on the NYSE on May 20, 2024, and will continue to be traded under its current ticker symbol “KFRC.” Kforce’s common st...
- ABGSC Metals & Mining Research
- Adrian Gilani
- Olof Cederholm
Star Shine Holdings Group Ltd: 1 director
A director at Star Shine Holdings Group Ltd sold 60,000,000 shares at 1.200HKD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...
B.F. Holding S.p.A: 1 director
A director at B.F. Holding S.p.A bought 6,500 shares at 3.674EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
Banco Santander SA: 1 director
A director at Banco Santander SA bought 345,248 shares at 4.570EUR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders
Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders MALVERN, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, announced that Maria Maccecchini, Founder, President, and CEO of Annovis, issued a letter to stockholders providing a review of Phase II/III data from its Alzheimer’s study and sharing next steps. Dear Friends, The last few days have been very difficult. I received a lot of emails and phone calls that often expressed ange...
Spectral Medical Provides April Tigris Trial Update
Spectral Medical Provides April Tigris Trial Update • 105 patients enrolled • April represents a record breaking month for patient enrollment TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today provided an update on the Company’s Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion (“PMX”) in a randomized controlled trial of adults treated for endotoxemia and septic shock. Enrollment: Robust enro...
Distribution Solutions Group to Participate in Two Conferences: Barrin...
FORT WORTH, Texas--(BUSINESS WIRE)-- Distribution Solutions Group, Inc. (NASDAQ: DSGR) (“DSG” or the “Company"), a premier, multi-platform specialty distribution company today announced that management is participating in the following conferences, which include one-on-one meetings: 18th Annual Barrington Research Virtual Spring Investment Conference on Thursday, May 16, 2024 KeyBanc Capital Markets Industrials & Basic Materials Conference in Boston on Thursday, May 30, 2024 Presentations will be webcast and can be accessed through the investor relations section of the company’s websi...
Dime Announces Expansion in Williamsburg With Deposit-Focused Group
Dime Announces Expansion in Williamsburg With Deposit-Focused Group Dime continues to execute on growth plan HAUPPAUGE, N.Y., May 06, 2024 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”), announced that it has hired a deposit-focused Group that will cover the Williamsburg market. The Group will be led by John McDonough and Emanuel “Manny” Diconimakis. The Group was previously employed with the former Signature Bank and its successor, Flagstar Bank. Stuart H. Lubow, President and Chief E...
Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences
Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences BEDFORD, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for wet age-related macular degeneration (wet AMD), diabetic retinopathy, and other diseases and conditions of the eye, today announced that it will participate at two investor conferences in May: Citizens JMP Life Sciences Conference Fireside Chat Date:...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.